Your browser doesn't support javascript.
loading
Intrinsic Antibacterial Activity of Nanoparticles Made of ß-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis.
Machelart, Arnaud; Salzano, Giuseppina; Li, Xue; Demars, Aurore; Debrie, Anne-Sophie; Menendez-Miranda, Mario; Pancani, Elisabetta; Jouny, Samuel; Hoffmann, Eik; Deboosere, Nathalie; Belhaouane, Imène; Rouanet, Carine; Simar, Sophie; Talahari, Smaïl; Giannini, Valerie; Villemagne, Baptiste; Flipo, Marion; Brosch, Roland; Nesslany, Fabrice; Deprez, Benoit; Muraille, Eric; Locht, Camille; Baulard, Alain R; Willand, Nicolas; Majlessi, Laleh; Gref, Ruxandra; Brodin, Priscille.
Affiliation
  • Machelart A; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Salzano G; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France.
  • Li X; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France.
  • Demars A; Research Unit in Microorganisms Biology (URBM), Laboratory of Immunology and Microbiology , Université de Namur , Narilis , B-5000 Namur , Belgium.
  • Debrie AS; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Menendez-Miranda M; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France.
  • Pancani E; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France.
  • Jouny S; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Hoffmann E; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Deboosere N; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Belhaouane I; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Rouanet C; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Simar S; Université de Lille , Institut Pasteur de Lille , EA 4483, F-59000 Lille , France.
  • Talahari S; Université de Lille , Institut Pasteur de Lille , EA 4483, F-59000 Lille , France.
  • Giannini V; Institut Pasteur , Unit for Integrated Mycobacterial Pathogenomics, Paris , CNRS UMR 3525, 25 Rue du Dr. Roux , F-75015 Paris , France.
  • Villemagne B; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France.
  • Flipo M; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France.
  • Brosch R; Institut Pasteur , Unit for Integrated Mycobacterial Pathogenomics, Paris , CNRS UMR 3525, 25 Rue du Dr. Roux , F-75015 Paris , France.
  • Nesslany F; Université de Lille , Institut Pasteur de Lille , EA 4483, F-59000 Lille , France.
  • Deprez B; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France.
  • Muraille E; Research Unit in Microorganisms Biology (URBM), Laboratory of Immunology and Microbiology , Université de Namur , Narilis , B-5000 Namur , Belgium.
  • Locht C; Laboratory of Parasitology, Faculty of Medicine , Université Libre de Bruxelles , B-1070 Brussels , Belgium.
  • Baulard AR; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Willand N; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
  • Majlessi L; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France.
  • Gref R; Institut Pasteur , Unit for Integrated Mycobacterial Pathogenomics, Paris , CNRS UMR 3525, 25 Rue du Dr. Roux , F-75015 Paris , France.
  • Brodin P; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France.
ACS Nano ; 13(4): 3992-4007, 2019 04 23.
Article in En | MEDLINE | ID: mdl-30822386

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Drug Carriers / Beta-Cyclodextrins / Nanoparticles / Mycobacterium tuberculosis / Antitubercular Agents Limits: Animals / Female / Humans / Male Language: En Journal: ACS Nano Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Drug Carriers / Beta-Cyclodextrins / Nanoparticles / Mycobacterium tuberculosis / Antitubercular Agents Limits: Animals / Female / Humans / Male Language: En Journal: ACS Nano Year: 2019 Document type: Article Affiliation country: Country of publication: